Zexuan Ding

441 total citations
17 papers, 326 citations indexed

About

Zexuan Ding is a scholar working on Organic Chemistry, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Zexuan Ding has authored 17 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Biomedical Engineering and 4 papers in Molecular Biology. Recurrent topics in Zexuan Ding's work include Nanoplatforms for cancer theranostics (9 papers), Click Chemistry and Applications (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Zexuan Ding is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Click Chemistry and Applications (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Zexuan Ding collaborates with scholars based in China, Italy and Singapore. Zexuan Ding's co-authors include Zhibo Liu, Zhibin Guo, Ziyang Wang, Qunfeng Fu, Hao Wang, Chunhong Wang, Mengqi Chen, Jinming Hu, Guhuan Liu and Mengqi Chen and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Zexuan Ding

17 papers receiving 325 citations

Peers

Zexuan Ding
Sudath Hapuarachchige United States
William M. MacCuaig United States
Lucy E. Jennings United Kingdom
Xidan Wen China
Hyunseung Lee South Korea
Sanghee Lee South Korea
Zexuan Ding
Citations per year, relative to Zexuan Ding Zexuan Ding (= 1×) peers Fernando Cortezon‐Tamarit

Countries citing papers authored by Zexuan Ding

Since Specialization
Citations

This map shows the geographic impact of Zexuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zexuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zexuan Ding more than expected).

Fields of papers citing papers by Zexuan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zexuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zexuan Ding. The network helps show where Zexuan Ding may publish in the future.

Co-authorship network of co-authors of Zexuan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Zexuan Ding. A scholar is included among the top collaborators of Zexuan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zexuan Ding. Zexuan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yin, Xiaozhe, Zexuan Ding, Yu Li, et al.. (2025). Orchestrating intratumoral DC-T cell immunity for enhanced tumor control via radiotherapy-activated TLR7/8 prodrugs in mice. Nature Communications. 16(1). 6020–6020. 5 indexed citations
2.
Ding, Zexuan, Xiaozhe Yin, Yiyan Li, et al.. (2025). Single atom engineering for radiotherapy-activated immune agonist prodrugs. Nature Communications. 16(1). 6021–6021. 3 indexed citations
3.
Xu, Mengxin, et al.. (2024). Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy. Science Bulletin. 69(17). 2745–2755. 7 indexed citations
5.
Guo, Zhibin, Yi Han, Peng Tian, et al.. (2024). Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis. ACS Central Science. 10(12). 2321–2330. 7 indexed citations
6.
Sun, Qi, Jiyuan Li, Zexuan Ding, & Zhibo Liu. (2023). Radiopharmaceuticals heat anti-tumor immunity. Theranostics. 13(2). 767–786. 17 indexed citations
7.
Chen, Mengqi, et al.. (2023). An “AND” Logic‐Gated Prodrug Micelle Locally Stimulates Antitumor Immunity. Advanced Materials. 36(6). e2307818–e2307818. 16 indexed citations
8.
Guo, Zhibin, et al.. (2022). Radiotherapy‐Induced Cleavage of Quaternary Ammonium Groups Activates Prodrugs in Tumors. Angewandte Chemie International Edition. 61(34). e202205014–e202205014. 49 indexed citations
9.
Ding, Zexuan, et al.. (2022). Radiotherapy Reduces N-Oxides for Prodrug Activation in Tumors. Journal of the American Chemical Society. 144(21). 9458–9464. 76 indexed citations
10.
Guo, Zhibin, et al.. (2022). Radiotherapy‐Induced Cleavage of Quaternary Ammonium Groups Activates Prodrugs in Tumors. Angewandte Chemie. 134(34). 13 indexed citations
11.
Chen, Mengqi, et al.. (2022). A Molecular Logic Gate for Developing “AND” Logic Probes and the Application in Hepatopathy Differentiation. ACS Central Science. 8(6). 837–844. 47 indexed citations
12.
Wang, Chunhong, et al.. (2021). A Cationic Micelle as In Vivo Catalyst for Tumor‐Localized Cleavage Chemistry. Angewandte Chemie International Edition. 60(36). 19750–19758. 20 indexed citations
13.
Wang, Chunhong, et al.. (2021). A Cationic Micelle as In Vivo Catalyst for Tumor‐Localized Cleavage Chemistry. Angewandte Chemie. 133(36). 19903–19911. 2 indexed citations
15.
Ding, Zexuan, Guhuan Liu, & Jinming Hu. (2020). Ratiometric Fluorescent Mapping of pH and Glutathione Dictates Intracellular Transport Pathways of Micellar Nanoparticles. Biomacromolecules. 21(8). 3436–3446. 6 indexed citations
16.
Ding, Zexuan, Peng Liu, Dehong Hu, et al.. (2017). Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy. Biomaterials Science. 5(4). 762–771. 27 indexed citations
17.
Ding, Zexuan, Peng Liu, Huqiang Yi, et al.. (2016). Multifunctional theranostic nanoparticles for dual-modality imaging and magnetic targeted photodynamic therapy. Nanomedicine Nanotechnology Biology and Medicine. 12(2). 527–527. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026